Status:
RECRUITING
Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Guillain-Barre Syndrome (GBS)
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this retrospective observational single-center cohort study is to gain a deeper understanding regarding the frequency, the clinical and electrophysiologic characteristics (e.g., the diagnos...
Detailed Description
Guillain Barré Syndrome (GBS) is a rare and life-threatening neurological emergency. The aim of this retrospective study including adult GBS patients from the last 15 years treated at the University H...
Eligibility Criteria
Inclusion
- suspected diagnosis of GBS, who have been treated at the University Hospital of Basel from 01.01.2005-28.02.2021
Exclusion
- Patients with documented refusal of the general consent.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04829526
Start Date
March 1 2021
End Date
July 1 2026
Last Update
December 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic for Intensive Care Medicine; University Hospital Basel
Basel, Switzerland, 4031